{"id":"W4312114419","doi":"10.1016/j.jtho.2022.10.010","title":"Usage of Radiotherapy With Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations","year":2022,"lang":"en","type":"letter","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Osimertinib; Medicine; Bevacizumab; Oncology; Internal medicine; Lung cancer; Progression-free survival; Randomized controlled trial; Pneumonitis; Epidermal growth factor receptor; Cancer; Lung; Overall survival; Chemotherapy; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004843124,0.0001891777,0.0006917933,0.0002361854,0.0007087938,0.0006898189,0.0004364823,0.004415635,0.003614912],"category_scores_gemma":[0.003351936,0.0001521158,0.0006458572,0.0003968874,0.0003600307,0.0004798268,0.0001843091,0.002955974,0.000730196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002187422,"about_ca_system_score_gemma":0.00158188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00275042,"about_ca_topic_score_gemma":0.01156805,"domain_scores_codex":[0.9996892,0.0001037799,0.00004172223,0.00004444087,0.00005230326,0.00006858435],"domain_scores_gemma":[0.9985616,0.0007316253,0.000142827,0.00002810202,0.00008879678,0.0004471161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0294549,0.002351472,0.1319926,0.0007325673,0.0006194093,0.05675775,0.0006005244,0.004397032,0.01246422,0.004773568,0.4740764,0.2817795],"study_design_scores_gemma":[0.01183866,0.01651089,0.2457442,0.0009977663,0.001517243,0.09919483,0.001557724,0.01227084,0.006304694,0.01542329,0.5883794,0.0002605016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.2795063,0.01289199,0.0005508209,0.6528264,0.01206285,0.0001421149,0.001107445,0.0001127795,0.04079925],"genre_scores_gemma":[0.6499398,0.004339242,0.00119152,0.3084951,0.02282272,0.0001520936,0.0006174247,0.00005839656,0.01238369],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.004415635,"threshold_uncertainty_score":0.01587087,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02327696652951689,"score_gpt":0.3954120527013132,"score_spread":0.3721350861717963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}